Test Price
2,800 AED✅ Home Collection Available
LAMC1 Gene Dandy-Walker Malformation & Occipital Cephalocele NGS Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015-accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance by certified genetics counsellors for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LAMC1 gene NGS test detects pathogenic variants associated with Dandy-Walker malformation and occipital cephaloceles, enabling precise diagnosis and recurrence risk assessment. This comprehensive analysis utilizes next-generation sequencing to cover all coding exons and flanking intronic regions of the LAMC1 gene.
| Feature | Our Test (LAMC1 NGS) | Closest Alternative |
|---|---|---|
| Precision & Method | Full gene sequencing with 100% coverage of exons ±10 bp flanking intronic regions | Targeted Sanger sequencing—limited regions, may miss deep intronic variants |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Clinical Utility | Comprehensive detection for diagnosis, family planning, and genetic counselling | Basic variant confirmation only |
Physician Insight & Safety Protocols
“This NGS test offers high-resolution detection of LAMC1 variants; however, results must be correlated with clinical neuroimaging and a formal genetics consultation for definitive diagnosis and management. This analysis is a critical component of a comprehensive diagnostic workup, not a standalone tool.”
— Consultant Medical Genetics Lina Osama Zaki Quteineh, DHA License: 9294403
Advisory Guidelines
Genetic testing provides powerful information. It is strongly advised to continue all prescribed medications and consult with your specialist before making any changes to your treatment plan based on these results.
Exclusion Criteria & Safety Red Flags
- Not indicated for asymptomatic individuals without a clinical or family history suggestive of LAMC1-related disorders.
- Not a routine prenatal screening; requires pre-test genetic counselling and informed consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Immediate medical attention is needed if the patient develops sudden severe headache, persistent vomiting, altered consciousness, or signs of raised intracranial pressure (e.g., bulging fontanelle in infants).
- Do not delay emergency care while awaiting genetic results.
Patient FAQ & Clinical Guidance
1. What is the LAMC1 gene test used for?
This NGS test identifies disease-causing mutations in the LAMC1 gene, which are linked to Dandy-Walker malformation and occipital cephaloceles. The results help guide clinical management and provide recurrence risk assessment for family planning.
2. How is the sample collected?
A standard peripheral blood sample is required. Our VIP Mobile Phlebotomy service provides convenient home collection with temperature-controlled cold-chain transport to ensure DNA integrity, available daily from 8 AM to 11 PM.
3. How is my insurance handled for this test?
We facilitate direct billing with major UAE insurers. For instant verification of your coverage and to understand any out-of-pocket costs, please contact our WhatsApp support at +971 54 548 8731 before booking.
UAE Regulatory & Data Privacy Adherence
Your genetic data is handled with the highest security standards. This test is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring your privacy and safety throughout the diagnostic process.
Clinical & Logistical Metadata
| Test Name | LAMC1 Gene NGS (Dandy-Walker Malformation & Occipital Cephalocele) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene sequencing with CNV analysis |
| ICD-10-CM Code | Q04.8, Q01.0 |
| LOINC Code | 95613-8 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians